Westaim Announces Amalgamation Agreement with NUCRYST Pharmaceuticals

Submit press release

Existing customer?
Log in

New customer?
Sign up

Latest Headlines
Motorola Mobility Notifies Certain Purchasers of Refurbished Motorola...
DNR Commemorates Conservation Officer's Death, Honors His...
Campaign tackles domestic violence ahead of Six Nations...
Justice Department Announces Luke J...
City of Lansing's River Trail closed at the M-43/Saginaw Street...
Michigan Liquor Control Commission Offers Tips on How to Host a...

M2 Archive: Preview

You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.

Westaim Announces Amalgamation Agreement with NUCRYST Pharmaceuticals
Toronto, ON -- The Westaim Corporation (TSX: WED) today announced the execution of an amalgamation agreement with NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS). Under the agreement, NUCRYST will amalgamate with a newly-formed, wholly-owned subsidiary of Westaim (the "Amalgamation"). Under...

If you want to view the full text, you must first purchase archive credits.
Return to Archives
New Search